澳股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Imagion Biosystems

0.024

0.000

成交量：203.11万

成交额：5.08万

市值：1,177.42万

市盈率：-1.40

高：0.025

开：0.025

低：0.024

收：0.024

52周最高：0.055

52周最低：0.011

股本：4.91亿

流通股本：1.72亿

量比：1.55

换手率：1.18%

股息：- -

股息率：- -

每股收益(TTM):-0.017

每股收益(LYR):-0.046

净资产收益率：-2804.87%

总资产收益率：-83.89%

市净率：-3.05

市盈率(LYR):-0.52

数据加载中...

总览公司新闻资讯公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻资讯

医学影像公司Imagion Biosystems向FDA提交Magsense® Her2靶向显影剂二期试验新药临床试验申请

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/IBX.AU"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IBX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IBX.AU\",,,,,undefined,":{"symbol":"IBX.AU","market":"AU","secType":"STK","nameCN":"Imagion Biosystems","latestPrice":0.024,"timestamp":1770690806858,"preClose":0.024,"halted":0,"volume":2031125,"delay":0,"changeRate":0,"nameEN":"Imagion Biosystems","floatShares":172453894,"shares":490590239,"eps":-0.017095,"marketStatus":"交易中","change":0,"latestTime":"02-10 13:34:11 AEDT","open":0.025,"high":0.025,"low":0.024,"amount":50763,"amplitude":0.041667,"askPrice":0.025,"askSize":902642,"bidPrice":0.024,"bidSize":1357636,"shortable":3,"etf":0,"ttmEps":-0.017095,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1770699600000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.024,"openAndCloseTimeList":[[1770678000000,1770699600000]],"volumeRatio":1.552241,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IBX.AU\",,,,,undefined,":{"symbol":"IBX.AU","floatShares":172453894,"roa":"-83.89%","roe":"-2804.87%","lyrEps":-0.045985,"volumeRatio":1.552241,"shares":490590239,"dividePrice":0,"high":0.025,"amplitude":0.041667,"preClose":0.024,"low":0.024,"week52Low":0.011,"pbRate":"-3.05","psRate":"11.15","week52High":0.055,"institutionHeld":0,"latestPrice":0.024,"committee":0.2013,"eps":-0.017095,"divideRate":0,"volume":2031125,"delay":0,"ttmEps":-0.017095,"open":0.025,"prevYearClose":0.025,"prevWeekClose":0.023,"prevMonthClose":0.024,"prevQuarterClose":0.025,"fiveDayClose":0.024,"twentyDayClose":0.03,"sixtyDayClose":0.023,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBX.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2023-11-16","symbol":"IBX.AU","defaultRemindTime":1700089200000,"type":"split","dateTimestamp":1700053200000,"forFactor":40,"toFactor":1,"ratio":40}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBX.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1161971983","title":"医学影像公司Imagion Biosystems向FDA提交Magsense® Her2靶向显影剂二期试验新药临床试验申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1161971983","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161971983?lang=zh_cn&edition=fundamental","pubTime":"2026-02-04 00:30","pubTimestamp":1770136219,"startTime":"0","endTime":"0","summary":"医学影像技术企业Imagion Biosystems（ASX: IBX）已正式向美国食品药品监督管理局（FDA）提交新药临床试验申请（IND），计划开展其旗舰产品Magsense® Her2靶向显影剂的二期临床试验。该显影剂采用创新纳米技术，旨在通过高精度磁共振成像实现对HER2阳性肿瘤的早期识别与定位，为乳腺癌等癌症的精准诊疗提供新方案。此次IND获批后将启动多中心临床研究，进一步验证该显影剂的安全性与成像效能，有望填补现有HER2检测技术的可视化诊断空白。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBX.AU","BK7007"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/IBX.AU\",params:#limit:6,delay:true,,,undefined,":[]}}